Dr. John Cush RheumNow
3 years 9 months ago
Imaging in PMR
One of the major limitations of PMR management is the lack of a gold standard investigation or biomarker of disease activity.
https://t.co/sZtgWKAtFv https://t.co/4H4tAY6CIZ
Dr. John Cush RheumNow
3 years 9 months ago
Why treatment of pre-RA isn't ready for prime time
The ACR Great Debate was on "To treat or not to treat in pre-RA?" and it was stressed that autoimmunity may start well before clinical symptoms occur.
https://t.co/A0dx3PFyiJ https://t.co/wqBuM8XD7M
Dr. John Cush RheumNow
3 years 9 months ago
Familial Mediterranean Fever mimics
Dr Baspinar et al. performed a large case-control study in Turkey to assess whether acute abdomen episodes which led to appendectomies could be misdiagnosed as appendicitis rather than FMF-associated serositis.#ACR22
https… https://t.co/fHgeoLjNOu
Dr. John Cush RheumNow
3 years 9 months ago
Hydroxychloroquine: Cumulative Doses and Thresholds
Dr. Sheila Reyes ( @RHEUMarampa) discusses Abstracts 0982 and 0344 at #ACR22 Convergence.
https://t.co/k33LUNnTmV https://t.co/AJSBdT4rJC
Dr. John Cush RheumNow
3 years 9 months ago
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler ( @lianegensler discusses the following abstracts presented at #ACR22. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
https://t.co/0wCxKyFM0u https://t.co/8vaZ1ZncjF
Dr. John Cush RheumNow
3 years 9 months ago
Comorbidities in Ankylosing Spondylitis
Dr. Akhil Sood ( @AkhilSoodMD) discusses Abstract 1609 at #ACR22 Convergence.
https://t.co/tX0gP3mYmW https://t.co/PYLpoczz08
Dr. John Cush RheumNow
3 years 9 months ago
Vaccines Work!
Dr. Eric Dein ( @ericdeinmd) and Dr. Caoilfhionn Connolly discuss abstracts 2275 & 0797 at #ACR22 Convergence.
https://t.co/xXcs5yQPSi https://t.co/1C4Cj9Ykei
Dr. John Cush RheumNow
3 years 9 months ago
Systematic review of MSK findings in patients with acute lymphoblastic leukemia finds 29 pts with peripheral arthritis (7), axial manifestations (17), and osteolytic lesions (21 pts) & Vertebral Fx (4) Hypercalcemia in 9 cases. https://t.co/DhCMMlMs7f https://t.co/HjjL4aF22a
A survey of 317 carers and clinicians focused on psoriatic arthritis has set an agenda of the top 10 research questions for psoriatic arthritis (PsA).
A series of surveys were initated by the British Psoriatic Arthritis Consortium (BritPACT) and funded by the James Lind Alliance (JLA).
Dr. John Cush RheumNow
3 years 9 months ago
Comparison of 227 Systemic Sclerosis pts w/ & without ILD shows SSc-ILD to have more muscle Dz [OR 2.55], LVDD [OR 2.36], PAH [OR 9.13], dcSSc [OR 2.86], PLR [OR 1.005], elevated KL-6 [OR 2.03], and anti-Scl-70 [OR 3.1]. https://t.co/Pzx9N5rPcF https://t.co/F8mBQ1u5iL
The first large multi-ancestry genetics study of osteoarthritis (OA) has found 10 novel OA-associated genetic loci, and results showed some of the OA-associated regions are robustly found in every population ancestry studied.
Dr. John Cush RheumNow
3 years 9 months ago
Fat and bone are never alone: osteoporotic fracture in RA
Dr. David Liew ( @drdavidliew) discusses Abstract 889 at #ACR22. Abstract 889: Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis
https://t.co/jSFmOiQb6N https://t.co/JTXugoxofP
Dr. John Cush RheumNow
3 years 9 months ago
Gender Differences in axSpA
In abstract 1614, Dr. Poddubnyy presents the results of the PROOF study which assessed the probability of achieving inactive disease or low disease activity among males and females who were recently diagnosed with axSpA.
https://t.co/DL2TDgXJnG https://t.co/XSQxWWnQgD
